tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Basilea Pharmaceutica’s Phase 3 Study on Fosmanogepix: A Potential Game-Changer in Antifungal Treatment
PremiumCompany AnnouncementsBasilea Pharmaceutica’s Phase 3 Study on Fosmanogepix: A Potential Game-Changer in Antifungal Treatment
1M ago
Basilea Pharmaceutica Reports Strong Financial Growth and Strategic Milestones in H1 2025
Premium
Company Announcements
Basilea Pharmaceutica Reports Strong Financial Growth and Strategic Milestones in H1 2025
1M ago
Premium
Company Announcements
Basilea Pharmaceutica’s Phase 3 Trial: A Potential Game-Changer in Antifungal Treatment
2M ago
PremiumCompany AnnouncementsBasilea’s Phase 3 Study on Fosmanogepix: A Potential Game-Changer for Mold Infections
2M ago
Basilea Pharmaceutica’s Promising Future: Buy Rating Backed by Fosmanogepix Potential and Robust Valuation
Premium
Ratings
Basilea Pharmaceutica’s Promising Future: Buy Rating Backed by Fosmanogepix Potential and Robust Valuation
2M ago
Premium
Company Announcements
Basilea Pharmaceutica’s Fosmanogepix Study: A Potential Game-Changer in Antifungal Treatment
2M ago
Basilea Pharmaceutica Receives Buy Rating Backed by U.S. Government Funding and Promising Drug Developments
PremiumRatingsBasilea Pharmaceutica Receives Buy Rating Backed by U.S. Government Funding and Promising Drug Developments
3M ago
Basilea Secures $39 Million BARDA Funding for Antifungal Drug Development
Premium
Company Announcements
Basilea Secures $39 Million BARDA Funding for Antifungal Drug Development
3M ago
Premium
Company Announcements
Basilea Pharmaceutica’s Fosmanogepix Study: A Potential Game-Changer in Pharma
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100